Philip Astley-Sparke $REPL SEC Form 4 Insider Trading

Philip Astley-Sparke has filed a total of 4 insider trades in $REPL since 2021. Their most recent trade was a sale of 32,279 shares, made on May 20, 2025. Their largest trade was a sale of 37,928 shares, made on May 16, 2024. We estimate that they now own 1.4 million shares of $REPL, worth an estimated $13.7 million.

Insider Trading at $REPL

There have been a total of 86 insider trades reported at $REPL since 2021, with 0 shares purchased and 1.0 million shares sold. The most active insider traders in $REPL stock have been Pamela Esposito, Colin Love, and Konstantinos Xynos. The most recent trade was a sale of 32,279 shares reported by Philip Astley-Sparke (None), made on May 20, 2025.

$REPL Executives and Stock Owners with Insider Trades

• Pamela Esposito, Chief Business Officer

• Colin Love, Chief Operating Officer

• Konstantinos Xynos, Chief Medical Officer

• Robert Coffin, President & Chief R&D Officer

• Christopher Sarchi, Chief Commercial Officer

• Sushil Patel, Chief Executive Officer

• Sushil Patel, Chief Strategy Officer

• Tanya Lewis, Chief Dev. Op. Officer

• Andrew Schwendenman, Chief Accounting Officer

• Emily Luisa Hill, Chief Financial Officer

• Jean M. Franchi, Chief Financial Officer

• Philip Astley-Sparke, Chief Executive Officer

• Philip Astley-Sparke, Executive Chairman

• Sushil Patel, Chief Commercial Officer

• Tanya Lewis, Chief Dev. Op Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.